NYU Dataset

Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in Non-Small Cell Lung Cancer

UID: 10630
* Corresponding Author
Description

SHP2 plays critical roles in normal cell signaling and SHP2 inhibitors alone and in various combinations are being tested in multiple tumors with overactivation of the RAS/ERK pathway. This study showed that inhibiting the SHP2/RAS/ERK pathway triggers upregulation of CXCR2 ligands. In this study, C57BL/6J mice were used as the orthotopic allograft lung cancer model. They injected KP cells into the tail vein of each mouse and MRI was used to monitor tumor formation and progression. Mice were treated with vehicle or SHP099 daily by oral gavage. For CXCR1/2 inhibitor studies, mice were dosed with SX-682, either alone or in combination with SHP099. This dataset includes RNA sequencing data.

Subject of Study
Subject Domain
Keywords

Access

Restrictions
Free to All
Instructions
All the raw sequencing reads are deposited in Gene Expression Omnibus (GEO) database.
Access via GEO

Raw sequencing reads
Accession #: GSE180964

Associated Publications
Data Type
Equipment Used
Akoya Biosciences Vectra Polaris
BD LSR II
Bio-Plex 200 System
Bio-Rad C1000 Touch Thermal Cycler
Bruker BioSpec 70/30
Illumina NovaSeq 6000
Leica BOND RX
LI-COR Imaging System
Software Used
3D Slicer
bcl2fastq
CFX Manager
Enrichr
FlowJo
GraphPad Prism v9.0
iCellR v1.5.5
inForm v2.4.11
KNetL
t-SNE
UMAP
Grant Support